In some cancers, IL-34 inhibits cancer cell proliferation and motility, as well as monocyte-like cell differentiation, such as lung cancer (Wang et al., 2021), while it also plays a tumor-promoting role by acting directly on transformed cells to increase their proliferation in a series of cancers (Franzè et al., 2020). Here, IL34 is linked to lung cancer.